India to Germany: Nivolumab Export Trade Route
India has recorded 9 verified shipments of Nivolumab exported to Germany, representing a combined trade value of $4.4K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $484 USD. The leading Indian exporter is DR REDDYS LABORATORIES LIMITED, which accounts for 99% of total export value with 4 shipments worth $4.3K USD. On the buying side, PROTAGENE GMBH is the largest importer in Germany with $4.3K USD in purchases. The top 3 suppliers — DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD, ZYDUS LIFESCIENCES LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Germany Nivolumab corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $4.4K USD. The route is dominated by DR REDDYS LABORATORIES LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's nivolumab manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $484 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 30.4%, placing it at rank #15 among India's top nivolumab export destinations globally.
On the import side, key buyers of Indian nivolumab in Germany include PROTAGENE GMBH, SARTORIUS STEDIM BIOTECH GMBH, AB SCIEX GERMANY GMBH. PROTAGENE GMBH is the single largest importer with 6 shipments valued at $4.3K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portHYDERABAD AIR
Market Position
- Global rank#15
- Annual growth+30.4%
- Demand growth+27.2%
- Regulatory ease70/100
Top 10 Indian Nivolumab Exporters to Germany
Showing top 10 of 4 Indian suppliers exporting Nivolumab to Germany, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DR REDDYS LABORATORIES LIMITED Avg $1.1K per shipment | 4 | $4.3K | 99.3% |
| 2 | DR.REDDY'S LABORATORIES LTD Avg $10 per shipment | 2 | $20 | 0.5% |
| 3 | ZYDUS LIFESCIENCES LIMITED Avg $10 per shipment | 1 | $10 | 0.2% |
| 4 | INTAS PHARMACEUTICALS LIMITED Avg $1 per shipment | 2 | $2 | 0.0% |
This table shows the top 10 of 4 Indian companies exporting nivolumab to Germany, ranked by total trade value. The listed exporters are: DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD, ZYDUS LIFESCIENCES LIMITED, INTAS PHARMACEUTICALS LIMITED. DR REDDYS LABORATORIES LIMITED is the dominant supplier with 4 shipments worth $4.3K USD, giving it a 99% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Nivolumab Importers in Germany
Showing top 10 of 3 known buyers in Germany receiving Nivolumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian nivolumab in Germany include PROTAGENE GMBH, SARTORIUS STEDIM BIOTECH GMBH, AB SCIEX GERMANY GMBH. The largest importer is PROTAGENE GMBH, accounting for $4.3K USD across 6 shipments — representing 100% of all nivolumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PROTAGENE GMBH | 6 | $4.3K | 99.7% |
| 2 | SARTORIUS STEDIM BIOTECH GMBH | 1 | $10 | 0.2% |
| 3 | AB SCIEX GERMANY GMBH | 2 | $2 | 0.0% |
Top 10 Nivolumab Formulations Imported by Germany
Showing top 10 of 8 product formulations shipped on the India to Germany Nivolumab route, ranked by trade value
Germany imports a wide range of nivolumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — NIVOLUMAB TEST SAMPLES 1.1MLQTY:06 VIALSFOR TESTING USE ONLY — accounts for $3.6K USD across 2 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NIVOLUMAB TEST SAMPLES 1.1MLQTY:06 VIALSFOR TESTING USE ONLY | 2 | $3.6K | 82.3% |
| 2 | NIVOLUMAB TEST SAMPLES 1.1MLQTY:08 VIALSFOR TESTING USE ONLY | 1 | $740 | 17.0% |
| 3 | NIVOLUMAB BUFFER-2-30ML(QTY:4 TUBES)(FORTESTING PURPOSE ONLY)NOS | 1 | $16 | 0.4% |
| 4 | 01 GLASS BOTTLE-CONTAINING NIVOLUMAB(BULK) (ZRC-3276) DRUG PRODUCTLIQUID SOLUTION.NOS | 1 | $10 | 0.2% |
| 5 | NIVOLUMAB BUFFER-1-30ML(QTY:2 TUBES)(FORTESTING PURPOSE ONLY)NOS | 1 | $4 | 0.1% |
| 6 | NIVOLUMAB REFERENCE PRODUCT BATCH NO- ACF1936 MFG- JUN-22 EXP DT- MAY-25 | 1 | $1 | 0.0% |
| 7 | NIVOLUMAB DRUG SUBSTANCE BATCH NO- P45D47U40 MFG DT- DEC-23 EXP DT NA AS INV | 1 | $1 | 0.0% |
| 8 | NIVOLUMAB BUFFER SAMPLES30 ML02 TUBESFOR TESTING USE ONLY | 1 | $0 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 6 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's nivolumab exports to Germany are driven primarily by a handful of large-scale manufacturers. DR REDDYS LABORATORIES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Germany benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD, ZYDUS LIFESCIENCES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $484 USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as nivolumab test samples 1.1mlqty:08 vialsfor testing use only and nivolumab buffer-2-30ml(qty:4 tubes)(fortesting purpose only)nos, suggesting that buyers in Germany tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, PROTAGENE GMBH is the largest importer with 6 shipments worth $4.3K USD — representing 100% of all nivolumab imports from India on this route.
Route Statistics
- Trade Volume
- $4.4K
- Avg. Shipment
- $484
- Suppliers
- 4
- Buyers
- 3
- Transit (Sea)
- ~16 days
- Annual Growth
- +30.4%
Reverse Direction
Germany → India — Nivolumab (Import)Other Nivolumab Routes
Unlock the Full India to Germany Nivolumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 9 shipments on this route.
Frequently Asked Questions — India to Germany Nivolumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Nivolumab to Germany?
The leading Indian exporters of Nivolumab to Germany are DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD, ZYDUS LIFESCIENCES LIMITED. DR REDDYS LABORATORIES LIMITED holds the largest market share at approximately 99% of total trade value on this route.
Q What is the total value of Nivolumab exports from India to Germany?
India exports Nivolumab to Germany worth approximately $4.4K USD across 9 recorded shipments. The average value per shipment is $484 USD.
Q Which ports does India use to ship Nivolumab to Germany?
The most active port of origin is HYDERABAD AIR with 6 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Germany for Nivolumab?
The average transit time for Nivolumab shipments from India to Germany is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Germany Nivolumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.4% with demand growth tracking at 27.2%. The route is ranked #15 among India's top Nivolumab export destinations globally.
Q How many suppliers are active on the India to Germany Nivolumab route?
There are currently 4 active Indian suppliers exporting Nivolumab to Germany. The market is moderately concentrated with DR REDDYS LABORATORIES LIMITED accounting for 99% of total shipment value.
Q Who are the main importers of Nivolumab from India in Germany?
The leading importers of Indian Nivolumab in Germany include PROTAGENE GMBH, SARTORIUS STEDIM BIOTECH GMBH, AB SCIEX GERMANY GMBH. PROTAGENE GMBH is the largest buyer with 6 shipments worth $4.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Germany export trade corridor identified from Indian Customs (DGFT) records for Nivolumab.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 3 importers in Germany matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 9 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists